Articles From: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Impax Laboratories, Inc. of Class Action Lawsuit and Upcoming Deadline -- IPXL to SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of InterMune Inc. - ITMN


NEW YORK, July 1, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP announces the filing of a class action lawsuit against INSYS Therapeutics, Inc. ("INSYS" or the "Company") (Nasdaq:INSY) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY investment picks
NEW YORK, July 6, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Ocean Power Technologies, Inc. ("Ocean Power" or the "Company") (Nasdaq:OPTT) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ocean Power Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline -- OPTT investment picks
NEW YORK, July 20, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc ("OvaScience" or the "Company") (Nasdaq:OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS investment picks
NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Regado Biosciences, Inc. ("Regado" or the "Company") (Nasdaq:RGDO) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Regado Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- RGDO investment picks
NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against STAAR Surgical Company ("STAAR" or the "Company") (Nasdaq:STAA) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline -- STAA investment picks
NEW YORK , July 28, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Family Dollar Stores, Inc. ("Family Dollar" or the "Company") (NYSE: FDO) (ISIN: US3070001090) (CUSIP: 307000109) concerning the proposed acquisition of Family Dollar by Dollar Tree, Inc. Family Dollar shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or 888-476-6529, ext.
Sign-up for SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Family Dollar Stores, Inc. - FDO investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Impax Laboratories, Inc. of Class Action Lawsuit and Upcoming Deadline -- IPXL to SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of InterMune Inc. - ITMN
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices